4-(3-(3-Chloro-4-methylphenyl)ureido)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide

Catalog No. :
ACPLLN043
CAS No. :
705286-33-5
Molecular Formula :
C20H20ClN5O3S
Molecular Weight :
445.93

IUPAC Name:4-(3-(3-chloro-4-methylphenyl)ureido)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide

4-(3-(3-Chloro-4-methylphenyl)ureido)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3-(3-Chloro-4-methylphenyl)ureido)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
IUPAC Name4-(3-(3-chloro-4-methylphenyl)ureido)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
MDL No.MFCD03086404
Molecular FormulaC20H20ClN5O3S
Molecular Weight445.93
SMILESO=S(C1=CC=C(NC(NC2=CC=C(C)C(Cl)=C2)=O)C=C1)(NC3=NC(C)=CC(C)=N3)=O
InChI KeyHXCSOZSSDXWMAF-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 4-[[[(3-chloro-4-methylphenyl)amino]carbonyl]amino]-N-(4,6-dimethyl-2-pyrimidinyl)-
CAS No.705286-33-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPLLN043 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLLN043 route product structure diagram
    ACPLLN043705286-33-5
Inquiry

2. ACPLLN043 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLLN043 route product structure diagram
    ACPLLN043705286-33-5
Inquiry

Comments (0)